Start-Up Previews (07/2008)
A preview of the emerging health care companies profiled in the current, all-profiles issue of Start-Up. This month's profile groups are "Glioblastoma Start-Ups Get Specific," "Glaucoma Start-Ups Reach Critical Mass," and "ALS on the Cusp." Plus these Start-Ups Across Health Care: EarlySense, NeoChord, and Pantec Biosolutions.
You may also be interested in...
Transcend Medical is the first spin-off of ForSight Labs, an ophthalmology-focused incubator created by The Foundry. To treat glaucoma, Transcend's founders have developed a tiny device, the CyPass, that can be inserted with a needle in a patented procedure that only takes 5 to 10 minutes.
In the field of glaucoma, there are a lot of unknowns because it hasn't previously been feasible to continuously monitor intraocular pressure. Sensimed was formed to do just that. The young company is developing a sensor that would provide 24-hours worth of intraocular pressure data as an alternative to the point-by-point measurement systems available today. The company likens its device to the Holter monitor in cardiovascular disease-a device that can yield a comprehensive set of diagnostic data as a patient goes about his or her daily life.
Israeli start-up EarlySense is a new entrant in the patient supervision and monitoring market. Its EverOn supervision system allows patients to be easily and continuously supervised without any physical contact or connections.